Actual-world knowledge startup Crescendo Well being launched Thursday with $3.4 million from Outline Ventures and different traders.
WHAT THEY DO
The startup goals to gather longitudinal knowledge for scientific analysis, together with data from different healthcare encounters which may not be collected when sufferers select to take part in a trial.
The corporate companions with biopharma corporations, medical gadget producers and contract analysis organizations to supply different well being knowledge, like major care data, emergency room visits, lab checks and prescription fills.
Individuals can join on-line and agree which data they need to share. Crescendo works to gather their well being data by way of APIs and knowledge partnerships, converts it right into a format for researchers, and gives the info again to individuals by way of a affected person portal.
With the funding, the startup plans to create software program that permits its life science companions to review the long-term results of remedy and observe affected person outcomes.
“Sufferers taking part in scientific trials generate worthwhile well being knowledge all through their healthcare journey, so researchers shouldn’t be restricted to data gathered within the 4 partitions of a analysis clinic. Nonetheless, thus far, these exterior real-world knowledge parts weren’t accessible to trial sponsors at scale, which is why we’re constructing the equipment and assist required to alter the paradigm,” Sam Roosz, cofounder and CEO of Crescendo Well being, mentioned in an announcement. “We’re working in direction of a future the place analysis is seamlessly built-in with routine scientific care, making participation straightforward and accessible for sufferers from all backgrounds.”
Accumulating longitudinal knowledge gives a extra holistic view of a affected person’s well being, which might be particularly as researchers examine new therapies that might require lengthy follow-up intervals, IQVIA’s Adam Mariano and David Voccola advised Healthcare IT Information final yr.
One other firm centered on pulling knowledge from well being data is nference, which launched its nSights platform final yr. It collects de-identified affected person scientific knowledge from educational medical facilities, together with scientific notes, radiology outcomes, lab checks and electrocardiograms for researchers to make use of to develop therapeutics and diagnostics. nference additionally just lately introduced a partnership with Duke Well being.
German startup Temedica introduced it had raised one other €25 million late final yr, bringing its Sequence B to €42 million. The Munich-based firm presents the Permea real-world knowledge platform and builds digital companion apps, which permit sufferers to trace signs and drugs use.